A healthy 9-month-old boy is brought to the clinic by his mother, who is concerned about multiple golden-brown "bumps" on his trunk, head, arms and legs that developed soon after birth.
The Case
A healthy 9-month-old boy is brought to the clinic by his mother, who is concerned about multiple golden-brown “bumps” on his trunk, head, arms, and legs that developed soon after birth. She noticed that every time one of these lesions gets irritated, it swells and forms a red pruritic plaque. The blistering had improved since the newborn period, and his growth and development have been normal. There is no family history of any skin disorders.
DIANOSIS: Urticaria pigmentosa
Darier sign (urtication or blistering of a lesion after scratching or stroking) is pathognomonic for UP. It is caused by release of histamine from mast cells secondary to mechanical trauma.3,5 With increasing age it becomes more difficult to demonstrate the Darier sign. Although most infants and young children are not symptomatic, itching or signs of systemic histamine release (diarrhea, headache, gastrointestinal bleeding) may occur, necessitating further evaluation and treatment.
Systemic mastocytosis with bony and bone marrow involvement occurs in up to 2% of pediatric patients with UP and should be suspected in children with hepatosplenomegaly, flushing episodes, or peptic ulcer symptoms.2 However, even children with severe symptoms usually improve spontaneously by 5 to 10 years of age and most lesions regress. Progressive improvement can occur well into adolescence.
DIFFERENTIAL DIAGNOSIS
Urticaria pigmentosa lesions can be mistaken for urticaria, which are transient and not usually associated with hyperpigmentation.4 Pigmented nevi are mostly brown and black rather than golden brown and do not urticate. Café-au-lait macules present as uniform brown macules or patches and never have the leathery texture so characteristic of UP.
DIAGNOSIS
The diagnosis of pediatric UP usually is a clinical one, and the Darier sign is diagnostic. Biopsies are reserved only for lesions that are clinically inconsistent with UP.5 Systemic studies rarely are needed, but when systemic symptoms are present, the initial workup consisting of complete blood count with differential, chemistry panel, and liver enzymes is recommended.5 Skeletal surveys and bone marrow biopsies are warranted only in patients with UP with severe systemic symptoms.2
Stress ulcer prophylaxis does not provide prevention of gastrointestinal bleeding in neonates
December 4th 2023In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.
Recognize & Refer: Hemangiomas in pediatrics
July 17th 2019Contemporary Pediatrics sits down exclusively with Sheila Fallon Friedlander, MD, a professor dermatology and pediatrics, to discuss the one key condition for which she believes community pediatricians should be especially aware-hemangiomas.
Pz-cel granted FDA Priority Review to treat recessive dystrophic epidermolysis bullosa
November 28th 2023The FDA granted Priority Review to pz-cel following a phase 1/2 and a pivotal phase 3 study in which the treatment for recessive dystrophic epidermolysis bullosa (RDEB) demonstrated wound healing and pain reduction.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
Preterm infant HRQOL: Long-term impacts and determinants
October 21st 2023A recent study was highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition that shed light on the long-term impact of very preterm birth on the health-related quality of life (HRQOL) of infants and identified key determinants.